Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).

Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.

2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9
+1 418-666-7000, extension 274
+1 418-666-2776

Latest news

309 entries « ‹ 1 of 31 › »

Gilca V, Sauvageau C, Panicker G, De Serres G, Schiller J, Ouakki M, Unger ER

Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials.

Journal Article

Hum Vaccin Immunother, pp. 1-6, 2019.

Abstract | Links:

Zafack JG, Bureau A, Skowronski DM, De Serres G

Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials.

Journal Article

BMJ Open, 9 (5), pp. e026953, 2019.

Abstract | Links:

Skowronski DM, De Serres G

Evidence in a cluster randomized controlled trial of increased 2009 pandemic risk associated with 2008-09 seasonal influenza vaccine receipt.

Journal Article

Clin Infect Dis, 2019, ISSN: 1058-4838.

| Links:

Zafack JG, Toth E, Landry M, Drolet JP, Top KA, De Serres G

Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance In Quebec, Canada.

Journal Article

Pediatr Infect Dis J, 38 (4), pp. 377-383, 2019, ISSN: 0891-3668.

Abstract | Links:

Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter AL, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic.

Journal Article

Euro Surveill, 24 (15), 2019, ISSN: 1025-496X.

Abstract | Links:

Amini R, Gilca R, Boucher FD, Charest H, De Serres G

Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks.

Journal Article

Infection, 2019, ISSN: 0300-8126.

Abstract | Links:

Skowronski DM, De Serres G, Orenstein WA

Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation.

Journal Article

Clin Infect Dis, 2019, ISSN: 1058-4838.

| Links:

Skowronski DM, De Serres G

Application of the Test-Negative Design to General Laboratory Submissions.

Journal Article

JAMA Pediatr, 173 (2), pp. 195-196, 2019, ISSN: 2168-6203.

| Links:

Ducrocq J, Proulx JF, Levesque B, De Serres G, Wood H, Lemire M

Assessment of naturally acquired neutralizing antibodies against rabies Lyssavirus in a subset of Nunavik's Inuit population considered most at risk of being exposed to rabid animals.

Journal Article

Zoonoses Public Health, 2019, ISSN: 1863-1959.

Abstract | Links:

Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study.

Journal Article

Hum Vaccin Immunother, 15 (2), pp. 503-507, 2019.

Abstract | Links:

309 entries « ‹ 1 of 31 › »
Signaler des modifications

Active projects

  • (CV04 QC03) CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2017-06-01 to 2022-03-31
  • Centre hospitalier universitaire de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Interchangeabilité des vaccins VPH., Subvention, Ministère de la Santé et des Services sociaux, from 2011-03-29 to 2019-12-31

Recently finished projects

  • Canadian Immunization Research Network, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2014-06-01 to 2017-05-31
  • PHAC / CIHR Influenza Research Network, Subvention, Instituts de recherche en santé du Canada, from 2012-06-01 to 2019-03-31
Data provided by the Université Laval research projects registery